Loading stock data…
$11.27+0.67 (+6.32%)
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.
Turn Therapeutics Inc. in the Healthcare sector is trading at $11.27 with a market capitalization of $406M. Wall Street consensus targets $25.00 (2 analysts), implying a +121.8% move over the next 12 months. The stock is currently 31% below its 52-week high of $16.45, remaining 70.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.63M↓ | -$1.25M↑ | -$2.19M↓ | -$1.91M↓ | -$1.37M |
| Net Income | -$5.85M↓ | -$970,972↓ | $279,070↑ | -$1.90M↓ | -$1.24M |
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound ca...